A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.
Erratum: A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence / Tefferi, A., Al Ali, H.K., Barosi, G., Devos, T., Gisslinger, H., Jiang, Q., Kiladjian, J.J., Mesa, R., Passamonti, F., Mcmullin, M.F., Ribrag, V., Schiller, G., Vannucchi, A.M., Zhou, D., Reiser, D., Zhong, J., Gale, R.P.. - In: LEUKEMIA. - ISSN 0887-6924. - ELETTRONICO. - 31:(2017), pp. 1252-1252. [10.1038/leu.2017.2]
Erratum: A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence
VANNUCCHI, ALESSANDRO MARIA;
2017
Abstract
A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
leukemia pomalid.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
35.39 kB
Formato
Adobe PDF
|
35.39 kB | Adobe PDF | Richiedi una copia all'autore |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
